Previous studies have correlated liver damage in NASH or in alcoholic liver disease with increased CYP2E1 isoenzyme activity [20] or expression [21], thus, suggesting the important role of CYP2E1 in NASH pathogenesis [22] through modulation of fatty acids [23]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.